Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.64 | 8.68 |
| PEG Ratio (TTM) | 0.22 | -1.25 |
| P/S Ratio (TTM) | 0.88 | 1.29 |
| P/B Ratio (TTM) | 2.80 | 3.03 |
| P/FCF Ratio (TTM) | 35.79 | 6.60 |
| Price to 5YR AVG Earnings Ratio | 17.12 | 16.71 |
| Price to 5YR AVG FCF Ratio | 52.27 | 8.99 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.79% | 4.57% |
| ROE (TTM) | 13.27% | 21.23% |
| Net Profit Margin (TTM) | 4.10% | 7.43% |
| ROIC 5YR AVG | 22.21% | 14.53% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.28% | 168.56% | 101.80% |
| Revenue | -1.12% | 38.12% | 27.59% |
| Net Income | 2.70% | 169.93% | 102.30% |
| Cash Flow | 169.72% | 355.53% | 256.42% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.88 | 3.75 |
| Quick Ratio (TTM) | 2.72 | 3.05 |
| D/E Ratio (TTM) | 0.32 | 1.78 |
| Interest Coverage (TTM) | 16.89 | 31.83 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 6.99 | 2.35 |
| LTL to 5YR AVG FCF | 5.09 | 5.47 |
| Shares Outstanding Growth 5YR AVG | -0.15% | -3.54% |